61755-0056 LYNOZYFIC - CanMED: NDC

Product NDC:

61755-0056

Brand Name:

LYNOZYFIC

Generic Name:

Linvoseltamab-gcpt

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: LINVOSELTAMAB

Strength: 200.0

Unit: mg/10mL

Packages:

Code: 61755-0056-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-056-01) / 10 mL in 1 VIAL, SINGLE-DOSE (61755-056-00)

Effective Date: July 2, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

BCMA, CD3

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox